Development of a Weighted Cardiometabolic Disease Staging (CMDS) System for the Prediction of Future Diabetes
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
CONTEXT: Metabolic syndrome traits are important risk factors for diabetes; however, each trait has different predictive power for future diabetes. Additionally, the impact of insulin resistance on metabolic profile can differ by gender and racial group, suggesting that gender-race specific prediction algorithms for diabetes may be warranted. OBJECTIVE: To develop a quantitative scoring system based on weighting of risk components in the cardiometabolic disease staging (CMDS) system for the prediction of future diabetes. DESIGN, SETTING, AND PARTICIPANTS: We derived the CMDS score in 2857 participants with valid follow-up information on incident diabetes from the Coronary Artery Risk Development in Young Adults study and validated it in 6425 older participants from the Atherosclerosis Risk in Communities study. We assigned a simple integer value for each CMDS risk factor component. MAIN OUTCOME MEASURES: Incident diabetes. RESULTS: Fasting glucose, 2-hour glucose, waist circumference, and blood pressure components contributed similarly for the prediction of future diabetes (CMDS scores, 23, 21, 26, and 20, respectively). The area under the receiver operating characteristic curve was 0.7158 for the CMDS scoring system, whereas it was 0.7053 for the Framingham diabetes score. The CMDS components performed differently for prediction of future diabetes in Black and White men and women. The components with the highest predictive power for diabetes were waist circumference in Black men, 2-hour glucose in Black women, and fasting glucose in both White men and White women. CONCLUSIONS: The weighted CMDS score has high model discrimination power for diabetes and can be used clinically to identify patients for weight loss therapy based on differential risk for future diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The at-risk pool of persons at risk of T2D is large,878,879 and it is not feasible or safe to treat all persons aggressively using all the tools of obesity medicine.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [878]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The CMDS and ACC/AHA models were selected over the Framingham models due to their broader generalisability across populations and greater accuracy of prediction. 30 , 34”
From Tirzepatide and the 10‐year predicted risk of cardiovascular disease and type 2 diabetes in adults with obesity and prediabetes: A post hoc analysis from the three‐year SURMOUNT ‐1 trial (2025) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
Prevalence of Childhood and Adult Obesity in the United States, 2011-2012
Ogden, C. L., Carroll, M. D., Kit, B. K., & Flegal, K. M. (2014) · JAMA · doi:10.1001/jama.2014.732 · Cited by 8,072 · cited 1×
“However, with nearly 70% of US adults being overweight or obese (6), and due to concerns of safety and cost, it is impracticable to treat all overweight and obese subjects with medical or surgical therapy.”
BackgroundPrevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010
Flegal, K. M., Carroll, M. D., Kit, B. K., & Ogden, C. L. (2012) · JAMA · doi:10.1001/jama.2012.39 · Cited by 5,385
Flegal, K. M., Kit, B. K., Orpana, H., & Graubard, B. I. (2013) · JAMA · doi:10.1001/jama.2012.113905 · Cited by 3,998
(1989) · PubMed · Cited by 3,139
Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker
Heagerty, P. J., Lumley, T., & Pepe, M. S. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00337.x · Cited by 2,854 · cited 1×
“We compared the prediction power of the CMDS scoring system with the Framingham diabetes risk score by constructing receiver operating characteristic (ROC) curves (27) and calculating the area under the ROC curves (AUCs) on the basis of incident diabetes from the ARIC study.”
Method(1998) · PubMed · Cited by 2,737
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s067 · Cited by 2,245
Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus
Wilson, P. W. F., D’Agostino, R. B., Parise, H., Sullivan, L., & Meigs, J. B. (2005) · Circulation · doi:10.1161/circulationaha.105.539528 · Cited by 2,064 · cited 4×
“First Published Online August 4, 2015 Abbreviations: AUC, area under the ROC curve; BMI, body mass index; CARDIA, Coronary Artery Risk Development in Young Adults; CMDS, cardiometabolic disease staging; HDL, high-density lipoprotein; OGTT, oral glucose tolerance test; ROC, receiver operating characteristic; T2DM, type…”
BackgroundInfluentialCardia: study design, recruitment, and some characteristics of the examined subjects
Friedman, G. D., Cutter, G. R., Donahue, R. P., Hughes, G. H., Hulley, S. B., Jacobs, D. R., Liu, K., & Savage, P. J. (1988) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(88)90080-7 · Cited by 1,687 · cited 1×
“The CARDIA study (22) began in 1985–1986 and is a large, ongoing population study of 5115 young Black and White adults aged 18–30 years at intake from four sites in the United States, including Birmingham, Alabama; Chicago, Illinois; Minneapolis, Minnesota; and Oakland, California.”
BackgroundLow-Grade Systemic Inflammation and the Development of Type 2 Diabetes
Duncan, B. B., Schmidt, M. I., Pankow, J. S., Ballantyne, C. M., Couper, D., Vigo, A., Hoogeveen, R., Folsom, A. R., & Heiss, G. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1799 · Cited by 1,036
Klein, S., Burke, L. E., Bray, G. A., Blair, S., Allison, D. B., Pi-Sunyer, X., Hong, Y., & Eckel, R. H. (2004) · Circulation · doi:10.1161/01.cir.0000145546.97738.1e · Cited by 934
Multicenter, placebo-controlled trial of lorcaserin for weight management.
Smith, S. R., Weissman, N. J., Anderson, C. M., Sanchez, M., Chuang, E., Stubbe, S., Bays, H., & Shanahan, W. R. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909809 · Cited by 911
Allison, D. B., Gadde, K. M., Garvey, W. T., Peterson, C. A., Schwiers, M. L., Najarian, T., Tam, P. Y., Troupin, B., & Day, W. W. (2012) · Obesity · doi:10.1038/oby.2011.330 · Cited by 711 · cited 1×
“Recent approval of new weight loss medications (2, 3) has enabled a pharmaceutical approach for obesity therapy.”
BackgroundSelf-citationEdelstein, S. L., Knowler, W. C., Bain, R. P., Andres, R., Barrett-Connor, E. L., Dowse, G. K., Haffher, S. M., Pettitt, D. J., Sorkin, J. D., Muller, D. C., et al. (1997) · Diabetes · doi:10.2337/diab.46.4.701 · Cited by 641 · cited 1×
“Elevated 2-hour glucose has previously been used in several diabetes prediction algorithms (16, 32).”
MethodEdelstein, S. L., Knowler, W. C., Bain, R. P., Andres, R., Barrett-Connor, E. L., Dowse, G. K., Haffner, S. M., Pettitt, D. J., Sorkin, J. D., Muller, D. C., et al. (1997) · Diabetes · doi:10.2337/diabetes.46.4.701 · Cited by 641
Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts
The DECODE Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.1.61 · Cited by 608
Identifying Individuals at High Risk for Diabetes
Schmidt, M. I., Duncan, B. B., Bang, H., Pankow, J. S., Ballantyne, C. M., Golden, S. H., Folsom, A. R., Chambless, L. E., & for the Atherosclerosis Risk in Communities Investigators (2005) · Diabetes Care · doi:10.2337/diacare.28.8.2013 · Cited by 455 · cited 2×
“Although other diabetes prediction algorithms included a blood pressure component (17, 26, 28), the underlying mechanism for the linkage between insulin resistance and elevated blood pressure remains to be fully elucidated.”
BackgroundKip, K. E., Marroquin, O. C., Kelley, D. E., Johnson, B. D., Kelsey, S. F., Shaw, L. J., Rogers, W. J., & Reis, S. E. (2004) · Circulation · doi:10.1161/01.cir.0000115514.44135.a8 · Cited by 412 · cited 1×
“From this perspective, baseline BMI can be less important than the existence and severity of complications at baseline in identifying patients who will benefit most from weight loss (11).”
BackgroundStandards of Medical Care in Diabetes—2015: Summary of Revisions
(2015) · Diabetes Care · doi:10.2337/dc15-s003 · Cited by 382
Limitations in the Use of Indices Using Glucose and Insulin Levels to Predict Insulin Sensitivity
Pisprasert, V., Ingram, K. H., Lopez-Davila, M. F., Munoz, A. J., & Garvey, W. T. (2013) · Diabetes Care · doi:10.2337/dc12-0840 · Cited by 302
Self-citationGarvey, W. T., Garber, A. J., Mechanick, J. I., Bray, G. A., Dagogo-Jack, S., Einhorn, D., Grunberger, G., Handelsman, Y., Hennekens, C. H., Hurley, D. L., et al. (2014) · Endocrine Practice · doi:10.4158/ep14280.ps · Cited by 238 · cited 1×
“This is consistent with the complicationscentric algorithm for obesity management (35) as advocated by the American Association of Clinical Endocrinologists that targets more aggressive therapy to those patients who will benefit most from the intervention based on risk and severity of weight-related complications (36).”
MethodSelf-citationLiao, Y., Kwon, S., Shaughnessy, S., Wallace, P., Hutto, A., Jenkins, A. J., Klein, R. L., & Garvey, W. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.4.978 · Cited by 218
Self-citationTwo Risk-Scoring Systems for Predicting Incident Diabetes Mellitus in U.S. Adults Age 45 to 64 Years
Kahn, H. S., Cheng, Y. J., Thompson, T. J., Imperatore, G., & Gregg, E. W. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00002 · Cited by 205 · cited 2×
“Although other diabetes prediction algorithms included a blood pressure component (17, 26, 28), the underlying mechanism for the linkage between insulin resistance and elevated blood pressure remains to be fully elucidated.”
BackgroundBlood pressure and risk of developing type 2 diabetes mellitus: The Women's Health Study
Conen, D., Ridker, P. M., Mora, S., Buring, J. E., & Glynn, R. J. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm400 · Cited by 203 · cited 1×
“Although other diabetes prediction algorithms included a blood pressure component (17, 26, 28), the underlying mechanism for the linkage between insulin resistance and elevated blood pressure remains to be fully elucidated.”
BackgroundGuo, F., Moellering, D. R., & Garvey, W. T. (2014) · Obesity · doi:10.1002/oby.20585 · Cited by 202 · cited 1×
“To better categorize the risk levels of people with excess body weight, we have established five stages of cardiometabolic disease risk—the cardiometabolic disease staging (CMDS) system (12) based on Adult Treatment Panel III metabolic syndrome risk factors (13, 14)—to guide decision making for selection of treatment…”
MethodSelf-citationHaffner, S. M., Howard, G., Mayer, E., Bergman, R. N., Savage, P. J., Rewers, M., Mykkänen, L., Karter, A. J., Hamman, R., & Saad, M. F. (1997) · Diabetes · doi:10.2337/diab.46.1.63 · Cited by 194
Mechanick, J. I., Garber, A. J., Handelsman, Y., Garvey, W. T., Beir, D. M., Bohannon, N. J. V., Bray, G. A., Bush, M. A., Evans, J. G., Hurley, D. L., et al. (2012) · Endocrine Practice · doi:10.4158/ep12160.ps · Cited by 160 · cited 2×
“tance and cardiometabolic disease, and the mechanical consequences of excess body weight (5).”
BackgroundSelf-citationGuo, F., Moellering, D. R., & Garvey, W. T. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0128 · Cited by 139 · cited 1×
“4%) to identify prediabetes (33) can also be problematic because hemoglobin A1c has high specificity but low sensitivity when identifying prediabetes diagnosed using fasting and 2-hour glucose values (34).”
BackgroundSelf-citationThalacker-Mercer, A. E., Ingram, K. H., Guo, F., Ilkayeva, O., Newgard, C. B., & Garvey, W. T. (2014) · Diabetes · doi:10.2337/db13-0396 · Cited by 93
Self-citationGarvey, W. T. (2013) · Endocrine Practice · doi:10.4158/ep13263.ra · Cited by 84
Self-citationIngram, K. H., Lara‐Castro, C., Gower, B. A., Makowsky, R., Allison, D. B., Newcomer, B. R., Munoz, A. J., Beasley, T. M., Lawrence, J. C., Lopez‐Ben, R., et al. (2011) · Obesity · doi:10.1038/oby.2011.45 · Cited by 52
Self-citationPower, C., Pinto Pereira, S. M., Law, C., & Ki, M. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.01.032 · Cited by 42
Prediction of Incident Diabetes Mellitus in Middle-aged Adults: The Framingham Offspring Study
Wilson, P. W. F. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.10.1068 · Cited by 4 · cited 3×
“Elevated 2-hour glucose has previously been used in several diabetes prediction algorithms (16, 32).”
BackgroundMethod
Cited by
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Self-citationMetabolically healthy obesity: facts and fantasies
Smith, G. I., Mittendorfer, B., & Klein, S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129186 · Cited by 645
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citationMechanick, J. I., Garber, A. J., Grunberger, G., Handelsman, Y., & Garvey, W. T. (2018) · Endocrine Practice · doi:10.4158/ps-2018-0139 · Cited by 104
Self-citationTHE CONCEPT OF NOVEL NATIONAL CLINICAL GUIDELINES ON OBESITY
Shlyakhto, E. V., Nedogoda, S. V., Конради, А. О., Баранова, Е. И., Fomin, V. V., Vertkin, A. L., & Chumakova, G. A. (2016) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2016-4-7-13 · Cited by 76
Metadata
- Authors
- Guo, F., & Garvey, W. T.
- Affiliations
- University of Alabama at Birmingham (US)
- Corresponding author
- Guo, Fangjian
- Garvey, W. Timothy
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-10
- Volume
- 100
- Issue
- 10
- Pages
- 3871-3877
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4596035
- OpenAlex
- W1866702143
- Cited by
- 44
- References
- 42
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 7 · 2021: 2 · 2020: 5 · 2019: 2 · 2018: 7 · 2017: 6 · 2016: 4 · 2015: 1
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01CX000432)
- National Institutes of Health (5p60dk079626-05)
- National Institute of Diabetes and Digestive and Kidney Diseases (P60-DK-079626, R01DK038765, DK038765, DK-083562, R01DK083562)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD055163)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- diabetes prediction, metabolic syndrome, risk scoring, insulin resistance, waist circumference, fasting blood glucose, 2-hour plasma glucose, blood pressure, sex differences, racial differences, black and white populations, weight loss treatment, Coronary Artery Risk Development in Young Adults, Atherosclerosis Risk in Communities Study
- MeSH terms
- Adolescent, Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Humans, Insulin Resistance, Male, Middle Aged, Predictive Value of Tests, Risk Factors, Incidence, Risk Assessment, Metabolic Syndrome, Waist Circumference, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.